Search by Drug Name or NDC

NDC 42291-0093-02 Albendazole 200 mg/1 Details

Albendazole 200 mg/1

Albendazole is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is ALBENDAZOLE.

MedlinePlus Drug Summary

Albendazole is used to treat neurocysticercosis (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). Albendazole is also used along with surgery to treat cystic hydatid disease (infection caused by the dog tapeworm in the liver, lung, and lining of the abdomen that may damage these organs). Albendazole is in a class of medications called antihelmintics. It works by killing the worms.

Related Packages: 42291-0093-02
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Albendazole

Product Information

NDC	42291-0093
Product ID	42291-093_ff952234-87d7-da18-e053-6394a90aea48
Associated GPIs	15000002000320
GCN Sequence Number	019283
GCN Sequence Number Description	albendazole TABLET 200 MG ORAL
HIC3	W4L
HIC3 Description	ANTHELMINTICS
GCN	53290
HICL Sequence Number	007864
HICL Sequence Number Description	ALBENDAZOLE
Brand/Generic	Generic
Proprietary Name	Albendazole
Proprietary Name Suffix	200 mg
Non-Proprietary Name	Albendazole
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	ALBENDAZOLE
Labeler Name	AvKARE
Pharmaceutical Class	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA210011
Listing Certified Through	2024-12-31

Package

NDC 42291-0093-02 (42291009302)

Pricing Information	N/A
NDC Package Code	42291-093-02
Billing NDC	42291009302
Package	2 TABLET, FILM COATED in 1 BOTTLE (42291-093-02)
Marketing Start Date	2020-05-15
NDC Exclude Flag	N